Prader Willi Syndrome Therapeutics Market: Is 2026 the Year We...

أضاف وظيفة جديدة Health

2026-02-13 07:05:02 - ترجمة

Prader Willi Syndrome Therapeutics Market: Is 2026 the Year We Finally Conquer Hyperphagia?

In early 2026, the Prader Willi Syndrome Therapeutics Market is valued at $575 million, marking a pivotal transition from purely hormonal management to specialized "hunger-blocking" science. This year, the industry is celebrating the first full year of commercial availability for VYKAT XR (diazoxide choline), which received landmark FDA approval in March 2025 as the first-ever treatment for...

0 التعليقات 0 المشاركات 69 مشاهدة 0 معاينة